Search research articles
Contact Us
Filters
Showing results (501-510 of 550) with videos related to
Page
of 55
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
September 24, 2019
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor
Giuseppe Lamberti, Antongiulio Faggiano, Nicole Brighi, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2018
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice
Margherita Nannini, Maria Concetta Nigro, Bruno Vincenzi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
S Stacchiotti, M Tortoreto, G G Baldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2017
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
S Stacchiotti, M Saponara, R Frapolli, et al.
Nature Communications
|
April 10, 2026
Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study
Mauro Cives, Giuseppina Della Vittoria Scarpati, Ottavia Clemente, et al.
Journal of Autoimmunity
|
July 28, 2020
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
Lorenzo M Canziani, Serena Trovati, Enrico Brunetta, et al.
Frontiers in Oncology
|
September 12, 2025
<i>POLE</i>-mutated endometrial cancer: new perspectives on the horizon?
Daniele Fanale, Lidia Rita Corsini, Paola Piraino, et al.
ESMO Open
|
January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
Andrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
Therapeutic Advances in Medical Oncology
|
October 7, 2021
Not all <i>KIT</i> 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)
Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, et al.
The Lancet. Gastroenterology & Hepatology
|
August 7, 2021
Computer-aided detection versus advanced imaging for detection of colorectal neoplasia: a systematic review and network meta-analysis
Marco Spadaccini, Andrea Iannone, Roberta Maselli, et al.
Page
of 55
Search research articles
Search
Showing results (501-510 of 550) with videos related to
Sort By:
Page
of 55
The Journal of Clinical Endocrinology and Metabolism
|
September 24, 2019
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor
Giuseppe Lamberti, Antongiulio Faggiano, Nicole Brighi, et al.
Therapeutic Advances in Medical Oncology
|
February 17, 2018
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice
Margherita Nannini, Maria Concetta Nigro, Bruno Vincenzi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
S Stacchiotti, M Tortoreto, G G Baldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2017
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
S Stacchiotti, M Saponara, R Frapolli, et al.
Nature Communications
|
April 10, 2026
Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study
Mauro Cives, Giuseppina Della Vittoria Scarpati, Ottavia Clemente, et al.
Journal of Autoimmunity
|
July 28, 2020
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
Lorenzo M Canziani, Serena Trovati, Enrico Brunetta, et al.
Frontiers in Oncology
|
September 12, 2025
<i>POLE</i>-mutated endometrial cancer: new perspectives on the horizon?
Daniele Fanale, Lidia Rita Corsini, Paola Piraino, et al.
ESMO Open
|
January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
Andrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
Therapeutic Advances in Medical Oncology
|
October 7, 2021
Not all <i>KIT</i> 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)
Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale, et al.
The Lancet. Gastroenterology & Hepatology
|
August 7, 2021
Computer-aided detection versus advanced imaging for detection of colorectal neoplasia: a systematic review and network meta-analysis
Marco Spadaccini, Andrea Iannone, Roberta Maselli, et al.
Page
of 55